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Abstract.  Cell sizes can differ vastly between cell 
types in individual metazoan organisms.  In rat liver, 
spleen, and thymus, differences in average cell size 
roughly reflect differences in RNA:DNA ratios.  For 
example, hepatocytes were found to have a cytoplas- 
mic:nuclear volume ratio and an RNA:DNA ratio 
which were 34- and 21-fold higher,  respectively, than 
those in thymocytes. RNA synthesis per DNA- 
equivalent in the hepatocytes was 25-fold greater than 
that in thymocytes, suggesting that differences in over- 
all transcriptional  activity, not differences in overall 
RNA stability, were primarily responsible for deter- 
mining cellular RNA:DNA ratios.  The mechanisms 
determining  the capacity of large cells to synthesize 
and accumulate more ubiquitous cytoplasmic macro- 
molecules, such as ribosomes, than smaller cells is en- 
titled "cell size regulation y 
Cell size regulation may have important conse- 
quences on the tissue distribution of transcription  fac- 
tors.  Thus,  in liver,  lung,  kidney, spleen, and brain, 
cellular levels of the mRNA encoding the leucine zip- 
per protein DBP correlate closely to cellular 
RNA:DNA ratios.  Our results suggest that DBP 
mRNA levels, like rRNA levels, are transcriptionally 
determined.  Thus the dbp gene, like the ribosomal 
genes, may be subject to cell size regulation.  As a 
consequence, nuclei from liver,  a tissue with a very 
large average cell size, accumulated higher levels of 
DBP protein than nuclei from small-celled tissues, 
such as spleen or lung.  In contrast to DBP, the ubiq- 
uitous transcription  factors Octl and NF-Y escaped 
cell size control.  Nuclei from most tissues contained 
similar amounts of these factors irrespective of cell 
size.  Likewise, tissues with large or small average cell 
sizes contained similar levels of the mRNAs encoding 
Octl or NF-Ya, one of the subunits of the heteromeric 
CCAAT-binding factor NF-Y, per DNA-equivalent.  In- 
terestingly, mRNA encoding NF-Yb,  another  subunit of 
NF-Y, was subject to cell size regulation.  Our results 
suggest that NF-Yb protein escapes cell size regulation 
at a posttranslational  level. 
Ein  the  19th century biologists  began  investigating 
the relationship  between nuclear  and cytoplasmic 
content.  In 1903, Hertwig hypothesized that the nu- 
clear:cytoplasmic ratio is a natural  constant.  Indeed, if one 
compares a single cell type between haploid and diploid sea 
urchin  embryos (Boveri,  1905),  one finds that  the diploid 
cells are twice as big as the haploid  cells.  Similar observa- 
tions have been reported in comparisons between differen- 
tially polyploid protozoan, plant, or amphibian  species (Ar- 
tom, 1912; Fankhauser,  1945; Gerassimow,  1902; Seyfert et 
al., 1984; Wettstein,  1928), in comparisons of genome sizes 
to  cell  sizes  between several  hundred  vertebrate  species 
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(Olmo, 1983), and even in comparisons of cell sizes between 
diploid and tetraploid  mouse embryos (Henery and Kauf- 
man,  1992). Clearly, a relationship between nuclear content 
and cell size exists. However, even as the studies above pro- 
vide observations  consistent with Hertwig's proposal,  the 
most cursory introduction  to histology allows one to refute 
the hypothesis.  Cell sizes  vary considerably between cell 
types having identical DNA content in individual metazoan 
organisms  (see Altman  and Katz,  1976). 
Why does cell size vary? The reasons are likely numerous 
and varied; however, to date, only theoretical  reasons can be 
given.  For example,  Szarski (1983) showed mathematically 
that  increases  in  cell  size will  reduce the energy cost for 
maintenance of gradients across membranes.  Moreover, one 
may  reason that,  for metabolically active  tissues  such  as 
liver, large cell size should maximize the per-cell metabolic 
capacity of the tissue. In contrast,  a recent study showed an 
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plexity of the visual centers in amphibian brains (Roth et al., 
1994), thereby suggesting that small cell size may favor intri- 
cate tissue architecture.  Finally, small cell size will increase 
the number of nuclei per unit volume, and should thereby al- 
low immune tissues such as spleen and thymus to store the 
maximal number of alternatively  recombined genomes. 
Several processes which contribute to cell size determina- 
tion have  received previous attention.  Some cell types ex- 
hibit mechanisms of regulated polyploidization which result 
in increased cell size (for review see Brodsky and Uryvaeva, 
1985). ]:or example, chromosome endoreplication followed 
by nuclear fusion during liver maturation in rodents leads to 
polyploidy and may  contribute to the large dimensions of 
adult parenchymal  cells (Nadal and Zajdela,  1966).  Some 
processes that might contribute to cell size differences with- 
out  changing  cellular  DNA  content  have  also  been  de- 
scribed. These include the accumulation of large quantities 
of cell  type-specific  products  such  as  myosin  in  muscle 
(Heywood et al., 1967), and the formation of large vacuoles 
in certain plant cell types (Matile,  1978).  Curiously, how- 
ever, previous cell size-related investigations have neglected 
one  fascinating  observation:  different  postreplicative  so- 
matic cell types in the body produce vastly different amounts 
of ubiquitous cytoplasmic materials, such as ribosomes, per 
unit of DNA  (see below). 
As a result of cell size differences, the relative volumes of 
nuclear to cytoplasmic compartments exhibit cell type-spe- 
cific differences. These volume differences are generally ac- 
companied by large differences in RNA:DNA ratios. For ex- 
ample, parenchymai hepatocytes accumulate over ten times 
more ribosomes per genome-equivalent  than  splenic lym- 
phocytes  (see  below)  suggesting  that  expression  of  the 
ribosomal genes is cell size dependent. The consequences of 
such  a cell  size-dependent  regulatory  mechanism  are  ex- 
pected to be particularly  intriguing for genes encoding nu- 
clear transcription  factors. Thus, if expression of a gene en- 
coding a transcription  factor were affected by cell size in a 
similar  way  as  the  ribosomal  genes,  the  cognate  protein 
would accumulate to higher nuclear concentrations in large 
cells as compared to small cells. As a consequence, this tran- 
scription factor may surpass the threshold concentration for 
efficient  target  gene  activation  only  in  large  cells.  Con- 
versely, the expression of a transcription  factor which is re- 
quired  at  similar concentrations  in  the  nuclei  of all ceils 
would have to be insensitive to cell size. 
In this study we show that nuclei from different cell types 
have  different  intrinsic rates  of overall transcription  which 
correlate with differences in  RNA  accumulation  and  cell 
size. These results suggest that rnetazoans  possess a hereto- 
fore unconsidered form of overall gene regulation which we 
entitle "cell size regulationY  As a result  of cell size differ- 
ences,  higher metazoans,  perhaps  unlike single-celled eu- 
karyotes,  must have independent mechanisms of controlling 
overall accumulation of ubiquitous cytoplasmic and ubiqui- 
tous nuclear macromolecules. The consequences of cell size 
regulation  on expression patterns  of nuclear  transcription 
factors are  investigated.  The results  suggest  that cell size 
regulation can largely account for the tissue-specific distri- 
bution of the PAR/leucine zipper protein DBP.  Conversely, 
the transcription  factors Octl and NF-Y accumulate to simi- 
lar levels in the nuclei of most cell types and thus appear to 
escape cell size regulation. 
Materials and Methods 
Animals, Tissue  and Explant Preparation, 
Morphometry, and Kinetic Labeling 
Male white rats and MORO mice were used for all studies. Hepatocyte ex- 
plants were prepared by modifications of the methods of Seglen (1976).  For 
morphometry, livers were perfused via the venaporta with 300-400 mi PBS 
supplemented with 1.1 mg/ml glucose; 3.7 mg/ml sodium bicarbonate; 25 
mM Hepes, pH 7.6; 0.5 raM EGTA; preequilibrated with 95% 02/5% C02 
(perfusate 1) at a rate of abont 25-40 ml/min at 370C. After starting perfu- 
sion, the vena cava was cut in the lower back region and the liver was care- 
fully dissected out of the animal and into a small tray maintained at 37°C 
while perfusion continued. Perfusate 1 was followed by 50 mi of perfusate 
2  (1.0 mg/ml collagenase  in  150  mM NaCI;  1.1  mg/mi glucose; 5  mM 
CaCI2;  25  mM Hepes, pH 7.6; 3.7 mg/rnl sodium bicarbonate; 0.1/zg/mi 
DNase 1 [Sigma Chem. Co., St. Louis, MO] preequilibrated with 95% 
02/5% C02) at a rate of*15 mi/min at 37°C. Perfusion was then stopped, 
the liver was transferred into a covered petri dish, and the dish was floated 
on a 37°C water bath tbr an additional 5-10 min. The liver was delicately 
teased open with needles and cells were washed out with several milliliters 
of TBS (10 mM Tris, pH 7.5 lat 25°C];  150 mM NaCI; 0.1 ~g/rni DNase 
1) at 37°C. Samples containing greater than 20%  inviable cells by trypan 
blue staining were discarded. The cell suspension was passed through a ny- 
lon mesh and mixed with two volumes of ice cold 4% glutaraidehyde in 
PBS. After incubation at 4°C overnight, the solution was decanted, cells 
were washed twice with PBS and incubated for 20 rain in PBS containing 
0.5 ~g/mi HOECHST's 33258 dye (Sigma Chem. Co.). Cells were washed 
two more times with PBS and mixed with roughly an equal volume of 50% 
glycerol; 50 mM "Iris, pH 7.5; 0.15 M n-propyl gallate (Sigma Chem. Co.); 
150 mid NaCI, placed on slides and covered with a free-floating coverslip 
(cells were not pressed between the slide and cover), and photographed un- 
der phase contrast or fluorescence,  40x  objective. 
During perfusion of the liver with perfusate 1, spleen and thymus were 
carefully removed and placed into petri dishes. We found that the resiliem 
tegument surrounding these organs will seal tightly around a hypodermic 
needle. Thus, 0.5 ml of perfusate 2 could be injected into each lobe of the 
thymus, or 1 mi of perfusate 2 into the spleen. Dishes were covered and 
floated on a 37°C water bath while liver perfusion was completed. The or- 
gans were ruptured with needles and the cells passed through nylon gauze. 
Trypan blue reliably showed >90%  cell viability  for both organs.  Subse- 
quent steps were identical as for the explanted bepatocytes. 
For morphometry, images were photographically enlarged an additional 
20x, and cells and nuclei were measured in the largest and smallest dimen- 
sions. Gravity dictates that the diameter of the cell in the third dimension 
will likely be less than or equal to the shortest diameter measured. Thus, 
volumes  were estimated using the equation v  =  4~rr[.rs2.3 -t, where rt  is 
1/2 the longest diameter and rs is  1/2  the shortest diameter. 
Cells for kinetic labeling were explanted by a modification of the proce- 
dure above.  PBS was replaced with 150 mM NaCI, glucose was omitted 
from perfusates, and perfusate 2 was supplemented with 1 mM hypoxan- 
thine (Sigma Chem. Co.). Labeling mix (2 ml/tissue type: DMEM (Sigma 
Dl152  +  3.7 mg/ml sodium bicarbonate; preequilibrated with 95% 0215% 
C02);  10%  newborn calf  serum  (GIBCO  BRL,  Gaithersburg,  MD);  5 
#Ci/ml  [5,6-3H]uridine  (New England Nuclear (Boston,  MA) NET367, 
37.5 Ci/mmol);  1 mM hypoxanthine;  1 mM EGTA;  1 mM MgCI2)  was 
preincubated at  37°C,  and 500 #1  of the explanted cell  suspension  was 
added. At the indicated times, a 250-/~1 aliquot was transferred  into a tube 
containing 250/.d 1× TES (10 mM Tris, 7.5; 5 mM EDTA;  1% SDS). Sam- 
ples received 40 ~! 3 M sodium acetate, pH 7.0;  1 ml ethanol, and were 
mixed at 4°C for 1 h followed by 1 h at -70°C. Precipitates were collected 
by centrifugation and resuspended in 400/zi GT (5 M guanidine thiocya- 
nate; 5 mM sodium citrate, pH 7.0; 0.1 M 2-mercaptoethanol; 0.5% sodium 
sarkosyl). FOr incorporation rates, a 200-#1 aliquot was precipitated with 
10%  "ICA, washed, and assayed by liquid scintillation.  For DNA assays, 
the remaining 200 ~1 of sample in GT was diluted to 400/~1  with GT, 40 
/tl 3 M sodium acetate, pH 7.0, was added, samples were extracted twice 
with ~/C/I (phenol/CHCl3/isoamyl alcohol; 25:24:1),  once with CHCI3, 
and were precipitated with ethanol. DNA content was determined by the 
fluorescent  assay described below. 
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procedures were performed in a  37°C ambient environment to maintain 
whole organ temperatures as near 37°C as possible. Liver was perfused first 
with 6 ml of perfusate 3 (25 mM Hepes, pH 7.6;  150 mM NaC1; 0.5 mM 
MgC12; 0.25  mM CaCI2;  50 nM hypoxanthine; 3.7 mg/ml sodium bicar- 
bonate;  preeqnilibrated with 95%  02/5%  C02)  at  roughly  10  ml/min, 
which was sufficient to visibly eliminate erythrocytes from the organ. The 
liver was then dissected out of  the animal, placed in a petri dish and perfused 
with 2-mi labeling mix (as above, but supplemented with 0.1% trypan blue; 
for amino acid incorporation, DMEM  +  10%  newborn calf serum was 
replaced by Met-free DMEM  +  0.5% FCS and a mixture of 35S-labeled 
amino acids [77% Met, 18% Cys; New England Nuclear, NEG-072, 1,000 
Ci/mmol] replaced the uridine) pumped at 10 ml/min. Labeling mix was 
then continuously pumped at ,~100 td/min. Trypan blue was chosen as the 
colorimetric indicator of perfusion homogeneity because it is not assimi- 
lated by live cells (Philips, 1973),  and thus is not expected to interfere with 
metabolism. As medium contained excess nonlabeled Cys, results represent 
Met incorporation. 
For spleen, a 23-gauge needle was slowly inserted through the organ in 
a petri dish as above while pumping perfusate 3. When near the distal end, 
the tip of the spleen was clipped and the needle was withdrawn to near the 
insertion point while pumping labeling mix, which traversed the entire or- 
gan en route to the exit at the far tip. Perfusion of labeling mix was continued 
at  100 ~d/min throughout the labeling period. 
The efficacy of the method was tested by measuring the amount of total 
tissue-associated radioactivity per unit DNA in five replicate snippets from 
perfused organs after quickly rinsing and blotting the surface of each sam- 
ple. This procedure was expected to remove radioactive fluid from the sur- 
face of  the tissue, but not remove radiolabel from the interstitial fluids. Liver 
and  spleen  showed  less  than  1.5-fold  maximal  variation  in  perfusion 
homogeneity by this method (average  +  SD:  liver, 708  5:124  cpm/ng 
DNA; spleen, 124 + 23 cpm/ng DNA). Thymus showed as much as sixfold 
variation in perfusion homogeneity (175 +  124 cpm/ng DNA) and therefore 
was not employed in this study. 
At the indicated time points, a small (,~100 ~d) snippet of a homogene- 
ously blue region of each tissue was excised, rinsed in PBS, blotted briefly 
on a clean paper wipe, and sonicated in 500/~1 TES. Lysates (400 t~l) were 
passed over a  1-ml G25-fine column in TES to r~move most nonincorpo- 
rated radioactivity; the remaining 100 td o~each lysate was extracted and 
precipitated for fluorescent DNA analysis (see below). The high molecular 
weight eluate from the column (1 ml) was precipitated with 400 ~1  10% 
"IV_A; 130/~1 12 M HCI, on ice >30 rain, washed with 1 M HC1, and assayed 
by liquid scintillation. 
Preparation of Nuclei and Nuclear Run-on Assays. Nuclei were pre- 
pared as described by Tian and Schibler (1991). Nuclear run-on assays were 
performed as described by Schibler et al. (1983) except that the specific ac- 
tivity of UTP was reduced (50/tM UTP containing 2.5 ~Ci [32p]/reaction 
with 30-150 ~g DNA-equivalents of nuclei). Because Mn  ++ hut not Mg  ++ 
is present in the run-on reaction, only RNA polymerase II (pol II) j elon- 
gates nascent transcripts efficiently (Roeder, 1976;  Schibler et al.,  1983). 
Run-on reactions (100 ~tl) were stopped after 13 min at 26°C by adding 520 
/.ti TES, 10 p.l 0.5 M EDTA, 50 pl 3 M sodium acetate, pH 7.0, 900/.tl etha- 
nol, and mixing at 4°C for 1 h followed by 1 h at -70oc. Control reactions 
contained 10/~1 0.5 M EDTA and were stopped immediately after adding 
nuclei. Precipitates were collected and resuspended by sonication in 420 ~,1 
TES. A portion (20 ~!) was removed, diluted to 400 t,1 with TES, extracted, 
and precipitated as above for fluorescent DNA analysis (see below). The 
remainder (400/~1)  was passed over a  1-ml G25-fine/TES column, acid 
precipitated, washed, and assayed for Cerenkov counts. 
Preparation of Total Nucleic Acid and RNA:DNA  Ratio Measure- 
ments. Numerous technical difficulties needed to be overcome in finding 
a satisfactory method for measuring RNA:DNA ratios in all tissue types. 
Indeed, published values for RNA and DNA quantities in tissues vary con- 
siderably (Ceriotti, 1955;  data compiled by Altman and Katz,  1976;  and 
references therein). The problems fall into four major categories: loss of 
specific nucleic acid species, interference by nonnucleic acid contaminants 
(most notably protein or polysaccharides), difficulties in discriminating 
RNA  from DNA,  and interference by reagents.  None of the published 
methods that we tested were satisfactory. Therefore, the following method 
was developed. 
Organs were homogenized in greater than 10 vol of either GT or TES 
1. Abbreviations  used in this paper: EMSA, electrophoretic mobility shift 
assay; pol II, RNA polymerase II. 
at room temperature. NaCI was added to 0.2 M and Tris, pH 8.0, was added 
to 10 raM, and an equal volume of ~/C/I was added. Phases were mixed 
and DNA sheared by sonication. To avoid depletion of DNA, during all ex- 
tractions any interphase material was harvested with the aqueous phase. Af- 
ter a second extraction the samples were precipitated with ethanol. Pellets 
were resuspended by brief sonication in TCS (10 mM Tris, pH 7.5; 0.5 mM 
CaC12; 1% SDS), pmteinase K was added to 40 ttg/ml, and samples were 
incubated at 50°C for 30 min. NaC! was added to 0.2 M, EDTA to 1 mM, 
samples were extracted twice with ~/C/I, once with CHCI3, and precipi- 
tated with ethanol. At this point, trace nucleosides and mononucleotides 
have been depleted by extractions and precipitations, lipids and soluble pro- 
teins have been extracted, and structural proteins have been digested and 
subsequently extracted. Samples are expected to contain all of the organ's 
polymeric nucleic acid, as well as some complex polysaccharides, such as 
glycogen. 
Precipitates were collected by centrifogation and resuspended by brief 
sonication in water. The amount of glycogen in liver samples at this point 
is too high to allow absorbance measurements, and can vary more than 10- 
fold between liver preparations depending on factors such as the time of  har- 
vest. Therefore, after sonication at room temperature, the aqueous samples 
were clarified in a microcentrifuge at room temperature for 3 rain. The large 
glycogen pellet in liver samples exhibited no coprecipitated nucleic acid by 
gel electrophoresis (not shown). The clarity of the supernatant suggested 
that roughly 80% of the glycogen was removed by this procedure. 
The following method for measuring RNA in the samples was developed. 
An aliquot of  the clarified aqueous solution was adjusted to 500/zl with wa- 
ter. A standard curve containing known amount of pure RNA and control 
samples containing known amounts of  pure DNA were prepared in parallel. 
Samples received 500 ~tl 1 M NaOH and were incubated at 50°C for 1 h 
to completely hydrolyze RNA without hydrolyzing DNA.  After samples 
were cooled 3 min on ice,  130 #1 of ice-cold 12 M HCI was added, and 
samples were incubated on ice 30 min to precipitate glycogen and DNA 
('IUA absorbs  UV light and would interfere with subsequent measure- 
ments). The short incubation time and low temperature prevented depurina- 
tion of DNA (confirmed by DNA controls). Samples were clarified by cen- 
trifugation; the supernatant was transferred to a  fresh tube,  heated for 
several minutes at 75"C (to acid hydrolyze residual polysaccharides), and 
absorbance at 260 nm was measured. Controls indicated less than 0.1% in- 
terference by DNA. Treatment of these iysates with orcinol (Sigma Chem. 
Co.; Ceriotti, 1955) indicated that although some glycogen-derived sugars 
persist in the supernatants, they no longer interfered with ultraviolet absor- 
bance measurements (not shown). 
To measure DNA in the aqueous samples, a fluorescent assay was used. 
The  assay  is based  on  DNA-specific intercalation and  fluorescence of 
HOECHST's 33258 dye by native DNA. It is important that samples never 
be heat or base denatured. The method we used was as described by Labarca 
and Paigen (1980),  except that we find optimal DNA-speeific fluorescence 
with an excitation wavelength of 352 rim, an emission wavelength of 450 
nm, and slit widths of 10 mm each on a LS-5B himinometer (Perkin-Elmer 
Corp., Norwalk, CT). Controls using either yeast RNA (primarily tRNA) 
or rat kidney RNA purified through a CsCI cushion (primarily rRNA) show 
less than 0.1%  interference. Purified rat glycogen at a concentration that 
yields an absorbance reading equivalent to 1 ~g/ml DNA shows 2.1% inter- 
ference (equivalent to 21  ng/ml DNA). In combination with the roughly 
fivefold depletion of glycogen by the centrifalgation step above, the assay is 
,~,200-fold less sensitive  to glycogen (and likely other polysaccharides) than 
direct absorbance assays; this was judged sufficient for our studies. 
RNA Purifrcation and RNase Protection Assays. A modification of  the 
method of Glisin et al. (1974) was used to purify RNA for RNase protection 
assays. Organs were homogenized in >10 vol of GT (5 M guanldine thiocya- 
nate; 5 mM sodium citrate, pH 7.0; 0.1 M 2-mercaptoethanol; 0.5% sodium 
sarkosyl), adjusted to 0.4 g/nil CsCI, and sonicated to reduce viscosity. 
Samples (5 ml) were layered onto 7-ml cushions of 5.7 M  CsCl;  l  mM 
EDTA in 12 ml 50I'i tubes, and sedimented for 16 h at 30,000 rpm, at 20"C 
(Beckman Iustrs., Fullerton, CA). Under these conditions, RNA sediments 
almost quantitatively (gel electrophoresis of samples shows mRNA, rRNA, 
and tRNA), but glycogen in liver samples forms a tight band '~1 cm from 
the bottom of the tube. 
RNase protection assays were as described previously (Schmidt and 
Merrill,  1989)  except that hybridization temperatures were reduced to 
52"C. To confirm data, RNase protection assays, except those using the NF- 
Ya probe (which hybridizes only to mouse NF-Ya mRNA), were repeated 
using RNA samples from both mouse and rat.  However, the only data 
shown from cross-species probe hybridization is that for GAPDH in Fig. 
8. For cross-species assays, conditions were as normal except that RNase 
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probes were used in the work presented: NF-Ya, a transcript complementary 
to mouse mRNA sequences between +1076  and  +1294 (Li et al.,  1992; 
note, this probe does not discriminate between the alternatively spliced iso- 
forms of NF-Ya mRNA, so results represent the sum of  both isoforms); NF- 
Yb, a transcript complementary to mouse mRNA sequences between +266 
and  +491  (Li et al.,  1992);  Octl, a transcript complementary to mouse 
mRNA sequences between +1175  and +1511  (Suzuki et al., 1993);  DBP, 
a transcript complementary to rat mRNA sequences between +370 and 
+505 (MueUer et al., 1990); GAPDH, a transcript colinear with a 200-base 
EcoR1-Accl region of the rat cDNA (Fort et al.,  1985);  albumin, a tran- 
script complementary to rat mRNA sequences between +1320 and +1720. 
To  confirm the specificity of the signals detected, the following probes 
directed to distinct regions of the mRNAs of interest were hybridized to 
RNA samples from large- and small-celled tissues sources: NF-Ya, a tran- 
script complementary to rat mRNA sequences between +1 and +144 (Li 
et al.,  1992);  NF-Yb,  a  transcript complementary to mouse mRNA se- 
quences between +492 and +752 (Li et al., 1992);  Octl, a transcript com- 
plementary to mouse mRNA sequences between +1 and +233  (Suzuki et 
al.,  1993);  DBP,  a transcript colinear with a genomic fragment spanning 
from  +600 to  +196  (Wuarin and Schibler,  1990).  In all cases, the cell 
size-dependent  expression patterns for these mRNAs were corroborated by 
both probes (not shown). 
Polysome Fractionation. Polysome fractions were prepared by a mod- 
ification of  the methods of  Schmidt and Merrill (1991). Preliminary analyses 
indicated that RNA harvested from polysome gradients of kidney,  spleen, 
brain, heart, and to a somewhat lesser extent lung, was degraded as visual- 
ized by denaturing gel electrophoresis (not shown). Only liver, which is rich 
in endogenous RNase inhibitors (Gribnau et al., 1969),  and testis yielded 
intact RNA. Thus, these two tissues were chosen for analysis of the NF-Yb 
polysome distribution. 
Mueller et al. (1990) demonstrated that DBP mRNA is expressed in all 
tissues except testis. Thus, an alternative system was required to measure 
the polysomal distribution of  DBP mRNA. For these studies, advantage was 
taken of the abundance of RNase inhibitors in liver and the circadian ex- 
pressing pattern of DBP mRNA. DBP mRNA is undeteetable in RNA sam- 
ples harvested in the early morning hours (<1% evening levels; Wuarin and 
Schibler, 1990;  and data not shown). Thus, morning liver provided a rich 
source of  DBP mRNA-free RNase inhibitor (the cost of  this amount of  com- 
mercial inhibitor would be prohibitive). Preliminary analysis demonstrated 
that fresh and frozen polysomal lysates gave indistinguishable polysomal 
gradients in terms of ultraviolet elution profiles, RNA integrity, and the dis- 
tribution of specific messages using lysates from either rat liver or tissue 
culture (Schmidt and Merrill, 1991; and data not shown). Therefore, liver 
was harvested from a rat killed at 8:00 am, homogenized at 4"C in 1 rrd/g 
tissue of 20 mM Tris, pH 7.6 (at 25"C);  150 mM NaCI;  10 mM MgCI2; 
10  mM  DTT;  20  #g/ml  cycloheximide in  a  motor-driven Teflon/glass 
homogenizer. Triton X-100  was added to  1%, nuclei wore pelleted in an 
HB-4 rotor at 0*C, 3 rain, 3,000 rpm (Sorvall Instrs., Wilmington, DE), 
and the supernatant was stored at -70°C until evening. At 5:00 pm, roughly 
1 g of liver or lung tissue from a littcrmate was homogenized in 10 ml each 
of the morning lysate (lung was chosen because preliminary experiments 
suggested that RNase levels were somewhat lower in lung lysates as com- 
pared to spleen, see above). Nuclei were sedimented as above, and 0.5 rnl 
of each lysate was layered on 15-50% sucrose gradients and sedimented as 
described (Schmidt and Merrill, 1991). A control gradient containing only 
the morning liver lysate confirmed that the DBP signal arose from the eve- 
ning liver or lung samples (not shown). 
Nuclear~Cytoplasmic RNA Preparation. Nuclei from liver and spleen 
of mice and rats killed at 3:00 pm (circadian peak of DBP transcription) 
were prepared by a modification of  the citric acid method (Wuarin and Schi- 
bier,  1990).  The low pH of the citric acid homogenization buffer allowed 
purification of intact nuclear RNA by inhibiting cellular RNases.  After 
homogenization  and filtration of  tissues and sedimentation of  nuclei through 
two 30%  sucrose pads as described (Wuarin and Schibler, 1990),  nuclear 
pellets were dispersed, nuclei were rapidly resuspended in 10 ml of ice cold 
NFB (40%  glycerol, 50 mM Tris, pH 8.3  (at 25°C),  5  mM MgCl2, 0.5 
mM EDTA) and pelleted for 3 rain, 0°C, 3,000 rpm in a Sorvall HB-4 rotor. 
Supernatants were removed and nuclear pellets were immediately sonicated 
in 6.5 ml GT.  CsC1 (3.2 g) was added and volumes were adjusted to 8 ml. 
Lysates were layered on 4-mi cushions of 5.7 M  CsC1;  1 mM EDTA, and 
RNA was pelleted in a Beckman Ti50 rotor at 39,000 rpm for 13 h, 20"C. 
RNA integrity was confirmed on stained formaldehyde/agarose gels. 
Other Methods and Reagents. Nuclear extracts were prepared and elec- 
trophoretic mobility shift assays (EMSA) performed by the methods of Lav- 
cry and Schibler (1993) using the rat albumin promoter C site oligonucleo- 
tide described by Wuarin et al. (1990) for NF-Y and the octamer-containing 
oligonucleotide described by Miiller et al.  (1988)  for Octl. Western blots 
were as per Descombes et al. (1990),  except for the analysis ofpol II large 
subunit, nuclear DNA was sheared at 37°C,  15 min, with 0.5  U/#g DNA 
of RQ1  DNase (Promega Corp.,  Madison, WI) in  1 mM MgC12 before 
adding SDS/dye mix and loading on gel, or as specified in figure legends. 
Figure 1.  Liver, spleen, and thymus histology in 5-wk-old rats. Semithin (0.5 #m) sections of fixed tissues embedded in plastic were pre- 
pared,  stained with toluidine blue,  and photographed.  All frames are the same magnification. 
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Cell Size Regulation 
Cell size varies greatly among cell types in metazoans (cell 
sizes from various species and tissue types are compiled 
in Altman and Katz [1976]).  This is exemplified by a mi- 
croscopic comparison between tissue  sections from liver, 
spleen, and thymus (Fig. 1). These three organs were chosen 
because, as seen in the micrographs, each is populated pre- 
dominantly by cells of similar size, but average cell sizes 
differ vastly between the organs. In comparing ceils in these 
three organs,  several  aspects  deserve attention:  first,  the 
amount of nuclear material per cell can vary (for review see 
Brodsky and  Uryvaeva,  1985).  Thus,  due to  polyploidy, 
most  liver nuclei  are  severalfold larger  than  the  diploid 
nuclei in spleen and thymus and several binucleate cells are 
observed in the liver micrograph. Second, the nuclei of liver 
cells  exhibit less  heterochromatin than  spleen or thymus 
nuclei.  The high proportion of decondensed euchromatin 
suggests that total transcriptional activity might be greater 
in liver (for review see Bouteille et al.,  1974). Finally and 
most importantly for this study, the micrographs show that 
the greatest difference in cell sizes resulted from a greater 
average cytoplasmic:nuclear volume ratio for liver than for 
spleen or thymus. Consistent with this, Table I shows that, 
in comparing six different organs, the wet mass of tissue per 
DNA equivalent varies over a 20-fold range. We hypothe- 
sized that the difference in cytoplasmic:nuclear ratios be- 
tween cell types may represent a regulated difference in the 
ability of nuclei to direct the steady-state accumulation of 
ubiquitous cytoplasmic material. 
RNA:DNA ratios were measured in eight organs to bio- 
chemically quantitate  relative accumulation of ubiquitous 
cytoplasmic material between different tissue types (Fig. 2). 
The amount of  total RNA per genome-equivalent  varied over 
a 16-fold range, with liver having an RNA:DNA ratio of 4.7 
and thymus a ratio of 0.3. Because the bulk of total RNA is 
rRNA, these data indicate that cells in the liver, on average, 
accumulated roughly 16-fold more ribosomes per unit DNA 
than cells in the thymus. 
For several reasons, we consider the RNA:DNA ratio the 
most reliable measure of differences in per-genome accumu- 
lation of ubiquitous cytoplasmic products.  First,  it is the 
most direct measure of the ability of the genome to direct the 
accumulation of  RNA. Thus, although a polyploid cell might 
produce more RNA as a result of having more gene copies, 
Table L  Per-genome Equivalent of Wet Tissue Mass 
for Various Organs 
Tissue  Tissue mass/DNA 
rag~rag  (% liver) 
Liver  870  (100) 
Lung  190  (22) 
Kidney  480  (55) 
Spleen  42  (5) 
Brain  890  (103) 
Thymus  32  (4) 
The indicated organs were harvested from an adult mouse, blotted briefly on 
clean paper wipes, and weighed. Total nucleic acid was extracted from each 
sample and the DNA content was determined. 
RNA:DNA ratios reflect relative per-genome RNA accumu- 
lation. Second, the RNA:DNA ratio provides a reproducible 
measure of average cytoplasmic:nuclear content within an 
organ which can be compared to other biochemical proper- 
ties of the tissue, such as specific mRNA or protein levels, 
and transcription or translation rates. Last, although tissue- 
specific functions may require different amounts of ribo- 
somes, tRNAs,  and total mRNA,  which will affect RNA: 
DNA ratios,  the RNA:DNA  ratios are blind to the accu- 
mulation of abundant tissue-specific products such  as  fat 
droplets in adilx~'~jtes, contractile proteins in myotubes, or 
extracellular materials in connective tissues or brain.  The 
methods we establish here may provide a reliable means of 
measuring RNA:DNA ratios in most biological samples. 
It was possible that differences in RNA:DNA ratios might 
represent differences in  RNA  concentration between  cell 
types and not differences in volume. To determine whether 
RNA:DNA ratios reflect differences in cell size, measure- 
merits were made on explanted hepatocytes, splenocytes, and 
thymocytes (Fig. 3). Total nucleic acid was prepared from 
a portion of the cells for biochemical analysis of RNA:DNA 
ratios in the explants. The remainder of the cells were fixed 
while in suspension and nuclear and cellular volumes were 
estimated  microscopically.  Comparison  of the  biochemi- 
cai and volumetric data in Fig.  3 A indicates that relative 
RNA:DNA ratios correlated reasonably well with relative 
cell sizes between these three cell types. 
In conclusion, the results above indicate that different cell 
types accumulate vastly different steady-state levels of total 
RNA per genome-equivaient. The differences in RNA:DNA 
ratios roughly correlated to differences in cytoplasmic:nu- 
clear volume ratios. We entitle the mechanism responsible 
for this difference, cell size regulation. To accumulate differ- 
ent steady-state levels of cellular RNA, cells must differ in 
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Figure 2. RNA:DNA ratios in adult organs. Total nucleic acid was 
prepared and used to measure RNA:DNA  ratios from three rats 
(ages 6, 7, and 9 wk) and four mice (ages 5, 7,  12, and 13 wk; all 
samples were prepared separately). L, U, K, S, B, and T were har- 
vested from all animals; H and Y were only harvested from rats. 
Data  represent average values; fine bars represent one standard 
deviation. The abbreviations L, liver; U, lung; K, kidney; S, spleen; 
B, brain; T, testis; H, heart; and Y, thymus, are used here and in 
subsequent figures. 
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Figure 3. Cell sizes, RNA:DNA ratios, and in vivo labeling kinetics for liver, spleen, and thymus. (.4) Measurements on explanted cells. 
Hepatocytes, splenocytes, and thymocytes were explanted from 7owk-old rat tissues. All photo frames are at the same magnification. Upper 
frames are phase-contrast micrographs; lower frames are HOECHST's dye fluorographs to allow measurements of nuclear volumes. In 
each case, upper and lower photos are of the same frames; erythrocytes in the splenocyte and thymocyte preparations exhibit no nuclei. 
Volumetric data represent average values for 15 hepatocytes, 14 splenocytes, and 32 thymocytes. The RNA:DNA ratios were determined 
on a separate aliquot of the same explants before fixation. Transcription rates represent the slope of the curves in B, and are listed here 
to facilitate comparisons. (B) In vivo uridine incorporation kinetics by explanted cells. Explanted cells were incubated in the presence 
of labeled uridine to measure overall transcription rates. Time points were taken at 2-min intervals and analyzed for acid-precipitable  radio- 
activity and DNA content. Values represent specific radioactivity  per input DNA. (C) Uridine incorporation by whole perfused liver and 
spleen. Snippets of each organ were harvested at 3-min intervals after initiation of perfusion with radiolabeled uridine. Values represent 
the acid-precipitable  radioactivity per unit DNA in each sample. (D) Amino acid incorporation by whole perfused liver and spleen. As 
in C, except that labeling mix contained radiolabeled amino acids. 
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which they degrade RNA, or both. 
Large Cells Synthesize More RNA Than Small Cells. Ki- 
netic studies of precursor incorporation rates were used to 
distinguish between the different mechanisms that might ac- 
count for cell size regulation. Three approaches were em- 
ployed in these  studies:  in vivo labeling using explanted 
cells, in vivo labeling using whole perfused organs, and in 
vitro labeling using isolated nuclei. 
In the first approach, uridine incorporation was measured 
in cells explanted from liver, spleen, and thymus (Fig. 3 B). 
Ufidine incorporation per unit time was divided by the mass 
of DNA in each sample as an indication of the per-genome 
transcription rams. The results show that the transcription 
rate per DNA in hepatocytes was ,~6- and 26-fold greater 
than rates in splenocytes and thymocytes,  respectively (tabu- 
lated in Fig.  3  A).  Significantly, if uridine incorporation 
rates per unit DNA are divided by the RNA:DNA ratios, all 
values fall within a twofold range (hepatoeytes: 156 cpm/t~g 
RNA.min;  splenocytes:  200  cpm/ttg  RNA.min;  thymo- 
cytes: 310 cpm/t~g RNA.min). Thus, differential transcrip- 
tion rates, rather than differential RNA stability, largely ac- 
counted for the different RNA:DNA ratios. 
As a second approach to measuring precursor incorpora- 
tion kinetics, whole liver and spleen were continuously per- 
fused with labeling media and small tissue pieces were har- 
vested at various time points. The amount of incorporated 
radioactivity was normalized to the amount of DNA in each 
sample. The results show that the uridine incorporation rate 
per unit DNA in liver was 5.7-fold greater than that in spleen 
(Fig. 3 C). The results confirm that RNA synthesis can ac- 
count for most of the difference in RNA:DNA ratios between 
liver and spleen. 
Methionine incorporation rates were measured in the per- 
fused organs as an indication of translational efficiencies. 
The results indicate that liver incorporated methionine at a 
per-genome rate that was 6.2-fold greater than that in spleen 
(Fig. 3 D). Comparison of methionine and uridine incorpo- 
ration rates between the perfused organs shows that rates of 
Table II.  In Vitro RNA Synthesis  in Isolated Nuclei 
Relative pol II 
Relative  transcription 
poi II 
Tissue  RNA/DNA  transcription  RNA/DNA 
mg/mg (% liver) 
Liver  4.71  (100)  100  1.0 
Lung  0.56  (12)  18  1.5 
Kidney  1.24 (26)  41  1.6 
Spleen  0.42  (9)  10  1.1 
Brain  1.44  (31)  34  1.1 
Thymus  0.30 (6)  9  1.5 
Run-on  transcription  rates  were determined  in  isolated  nuclei  under conditions 
which favor  pol  H-specific  elongation.  Values are  presented  as  percent  of  the 
liver  value to facilitate  comparison to RNA/DNA  values.  Control reactions 
were  stopped  immediately  and  thus  represent  a  zero  time  point.  The  following 
specific  values  are given  to show representative  signal  to background: liver: 
experimental, 52.3  gig DNA-equivalents  of nuclei yielded 51,000  cpm 
(Cerenkov); control,  58.  I ~g DNA-equivalents  of nuclei  yielded  662 cpm. 
Spleen:  experimental,  57.6 Itg  DNA-equivalents of  nuclei  yielded  6,240 cpm; 
control,  57.3 l~g  DNA-equivalents of  nuclei  yielded  357  cpm. The  correlation 
between  RNA/DNA  ratios  and  overall  pol  H transcription  rates  is  exhibited  in 
the  last  column by division  of  the  transcription  rate  values  by the  RNA/DNA 
ratio determinations. 
protein  and  RNA  synthesis  correlated  well  (compare Fig.  3, 
C and/9). Division of  the  per-DNA methionine incorpora- 
tion  rates  by the RNA:DNA  ratios  indicates  that  per-RNA 
rams  of  protein  synthesis  varied  by  less  than  twofold  between 
liver  and spleen. 
As  a  third  approach to  determining the  level  of  regulation 
of  RNA:DNA  ratios  in  different  tissue  types,  in  vitro  incor- 
poration  of  UTP was measured during run-on transcription 
in  isolated  nuclei  under  conditions  in  which only  RNA  poly- 
merase II (pol 11) efficiently elongates nascent transcripts 
(Table II; Gariglio et al., 1981). Relative differences in run- 
on transcription rate per unit DNA roughly reflected differ- 
ences in RNA:DNA ratios between the six tissue types ex- 
amined; only small differences in total RNA accumulation 
per transcription activity could be measured (last column in 
Table H).  In conclusion, all three approaches suggest that 
regulation of overall transcription rates, rather than of over- 
all RNA stabilities, largely account for the differences we 
measured in RNA:DNA ratios. 
Accumulation of RNA  Polymerase  H  in  Organs  with 
Differences  in  Cell Size.  Although differences in pol  II 
activity alone  cannot  account  for  differences in  cellular 
RNA:DNA ratios, the data in Table II indicate the pol II ac- 
tivity is cell size-dependent. Therefore, we asked whether 
these activity differences could be accounted for simply by 
differences in levels of pol lI pmmin. Western blots for pol 
II large subunit show that nuclear levels of the protein do not 
correlate well to relative RNA:DNA ratios (Fig. 4). Thus, 
although nuclei of small cells, such as spleen and lung, ex- 
hibited less pol II than those of  larger cells, such as liver, kid- 
hey, and brain, liver pol II levels did not appear higher than 
those in kidney. Also, testis (RNA:DNA =  1.1) exhibited at 
least as much pol II per unit DNA as liver (RNA:DNA  = 
Figure 4. RNA polymerase II large subunit in nuclei from various 
tissue sources. A Western blot of a 5.2% polyacrylamide  gel con- 
taining 20 ttg DNA-equivalents  per lane of whole DNase-treated 
nuclei from the indicated rat tissues was visualized using mouse 
monoclonal antibody to the CTD polypeptide of the large subunit 
of RNA polyrnerase and the ~ECL" method (Amersham Corp., 
Arlington Heights, IL). The top of  the photo corresponds to the top 
of the running gel; bands corresponding to phosphorylated (IIO) 
and underphosphorylated (HA) forms are indicated. The RNA: 
DNA ratios for the respective  tissues are listed below the autoradio- 
gram to ease comparison to signal intensities. 
Schmidt and Schibler Cell Size Regulation  473 4.7).  It  may  be  interesting  that  nuclear  levels  of under- 
phosphorylated pol II molecules (IIA) more closely matched 
differences in pol H-dependent transcription rates (Table II). 
Pol IIA has been proposed to play the primary role in initiat- 
ing transcription (for review see Corden,  1993).  However, 
until we can exclude the possibility that the equilibrium be- 
tween pol IIA and pol IIO was altered during the isolation 
of nuclei, we cannot be certain that the observed correlation 
is significant. In conclusion, overall levels ofpol H probably 
do not account entirely for cell size-dependent transcription 
rates. 
Gene Expression As a Consequence of Cell Size 
Genes Encoding Ubiquitous Transcription Factors Escape 
Cell Size Regulation.  Because cell  sizes differ,  two gen- 
eral  types of ubiquitous  macromolecules can  be  defined. 
Ubiquitous nuclear molecules, exemplified by DNA and his- 
tones,  are generally equally  represented in  most cells.  In 
contrast,  cellular  levels  of ubiquitous  cytoplasmic macro- 
molecules vary with cell size. This simple observation neces- 
sitates that genes encoding ubiquitous nuclear and ubiquitous 
cytoplasmic products be subject to distinct mechanisms of 
regulation. Because large and small cells accumulate similar 
steady-state  numbers  of most  ubiquitous  nuclear  macro- 
molecules per DNA,  cell  size regulation,  the  mechanism 
that directs greater synthesis of ubiquitous cytoplasmic mac- 
romolecules in cells with high RNA:DNA ratios, must be ei- 
ther  ignored  or overridden by genes encoding  ubiquitous 
nuclear products. To test this prediction, we investigated ex- 
pression patterns of three genes encoding ubiquitous nuclear 
proteins. 
As most nuclear macromolecules are synthesized in non- 
dividing cells only to compensate for turn over, and because 
synthesis rates equal degradation rates at steady-state, short- 
lived ubiquitous  nuclear macromolecules were sought for 
this study. We reasoned that the ubiquitous transcription fac- 
tors,  unlike  histones  and  perhaps most structural  nuclear 
proteins,  would  have  sufficiently  short  halflives  to  allow 
measurement of compensatory synthesis rates in postrepli- 
Figure 5. NF-Y  and Octl in tis- 
sues. (A) NF-Y-specific  DNA- 
binding activity in nuclei. The 
indicated volumes of nuclear 
extracts  (all  corresponding 
equal  DNA-equivalents  of 
nuclei/vol)  were  used  in  an 
EMSA  with  an  oligonucleo- 
tide  probe  corresponding  to 
the  rat  albumin  promoter C 
site.  (B)  NF-Ya and  NF-Yb 
protein levels. A Western blot 
(13%  polyacrylamide  gel) 
containing  50  #g  DNA- 
equivalents/lane  of  nuclear 
proteins  from  the  indicated 
tissues was visualized using a 
mixture  of rabbit  polyclonal 
antibodies raised against NF- 
Ya and against NF-Yb followed 
by  goat-anti-rabbit  alkaline 
phosphatase-conjugated  sec- 
ond  antibody.  (C)  Compari- 
son of relative levels of NF-Y- 
and  Octl-specific  DNA-bind- 
ing activity in tissues.  Equal 
DNA-equivalents  of  nuclear 
extracts from the indicated tis- 
sues were used in EMSA as- 
says  with  the  albumin  pro- 
rnoter  C  site  oligonucleotide 
(upper  autoradiogram)  or 
octamer-containing  oligonu- 
cleotide  (lower  autoradio- 
gram) in parallel to allow di- 
rect  comparison  of  relative 
levels of the  two DNA-bind- 
ing  activities  in  nuclei.  (D) 
mRNA levels for NF-Ya and 
Octl in tissues. RNase protection assays were performed using 50 #g per assay of total RNA harvested from the indicated mouse tissues. 
For both mRNA species, 5 fmol of the respective probe (55 Ci/mmol) was included in each hybridization.  The NF-Ya probe hybridizes 
to both isoforms of NF-Ya mRNA (see text and Materials and Methods),  such that the signal observed represents the sum of both mRNA 
isoforms in each sample. Abbreviations:  *a, residual nondigested NF-Ya riboprobe;  C, control lanes containing 50 #g of yeast RNA to 
show signal specificity. 
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were chosen for this study. Octl is a homodimeric transcrip- 
tion factor which is expressed at similar levels in nuclei from 
most tissue and tissue-culture sources (Barberis et al., 1987; 
Miwa et al., 1987; Schtler et al., 1989; Sturm et al., 1988; 
Suzuki  et  al.,  1993;  Tanaka et al.,  1992).  The  CCAAT- 
binding transcription factor NF-Y (CP1, CBF, HAP2/3/4) is 
a heteromer containing subunits NF-Ya, NF-Yb, and at least 
one other subunit (Chodosh et al.,  1988a,b; Forsburg and 
Guarente,  1989; Hatamochl et al.,  1988; Hooft van Huijs- 
duijnen et al.,  1990; Maity et al.,  1992). Two isoforms of 
NF-Ya and two isoforms of NF-Yb exist in nuclei from differ- 
ent tissue  and  cell types  (Hooft van  Huijsduijnen  et al., 
1990;  Li et al.,  1992;  Maity et al.,  1992;  Vuorio et al., 
1990).  The two isoforms of NF-Ya arise from differential 
splicing (Li et al., 1992) whereas the isoforms of NF-Yb re- 
sult from posttranslational modification (Malty et al., 1992). 
By all assays to date, both isoforms of NF-Ya and both iso- 
forms of NF-Yb exhibit indistinguishable activities (Li et al., 
1992; Malty et al., 1992; Mantovani et al., 1992), and there- 
fore were considered equivalent here. 
We first quantitated the levels of NF-Y and Octl in nuclei 
from different tissue sources to confirm that nuclei contain 
similar numbers of these ubiquitous transcription factors. 
Electrophoretic mobility shift assays (EMSA) using  serial 
dilutions of nuclear extracts demonstrated that NF-Y-depen- 
dent DNA-binding activity levels were similar in the differ- 
ent tissue types (Fig. 5 A). However, because NF-Y is a bet- 
eromeric factor, it was possible that the levels of any one 
subunit could limit NF-Y activity in different nuclei sources. 
Therefore, levels of NF-Ya and NF-Yb protein were measured 
by Western blot analysis (Fig. 5 B). NF-Ya and NF-Yb protein 
levels were both similar in nuclei from all six tissue types 
(within roughly twofold for the sum of  the isoforms for either 
protein). Because Octl binds DNA as a homodimer, it is pos- 
sible to estimate Octl  protein levels directly from EMSA 
analysis (Barberis et al.,  1987; Miwa et al.,  1987; Ossipow 
et al., 1993; Schtler et al., 1989; Sturm et al., 1988; Suzuki 
et  al.,  1993;  Tanaka  et  al.,  1992).  Comparison  of Octl- 
specific  to  NF-Y-specific  DNA-binding  activity  demon- 
strated that, with the exception of the previously described 
brain-specific  deficiency of Octl  activity  (Schtler et  al., 
1989), nuclei from different tissues contained similar levels 
of Octl- and NF-Y-specific DNA-binding activities (Fig.  5 
C). As Octl, NF-Ya, and NF-Yb were present at similar num- 
bers per DNA-equivalent in tissue types with vastly different 
RNA:DNA ratios, our results confirm that these proteins are 
not subject to cell size regulation. 
Regulation of Nuclear NF-Ya, NF-Yb, and Oct1 Protein 
Levels. Levels of mRNAs encoding NF-Ya, NF-Yb, and Octl 
were quantitated next to determine whether they also were 
cell size-independent. To correctly interpret mRNA analy- 
ses between different tissue types, the RNA:DNA ratios of 
the tissues were taken into consideration. As a result of the 
differences in RNA:DNA ratios, a given mass of total RNA 
will represent ll-fold more genome-equivalents of spleen tis- 
sue than of liver. The comparison of  50 #g of  total RNA from 
different tissue types in Fig. 5 D shows the relative concen- 
trations of NF-Ya and  Octl  mRNA.  The signal intensities 
must be multiplied by the RNA:DNA ratios to find the per- 
genome number of mRNA molecules. Because the relative 
signal  intensities  for  both  NF-Ya and  Octl  mRNA  were 
Figure 6. NF-Ya  and NF-Yb regulation in tissues. (A) NF-Ya  and NF- 
Yb  mRNA levels per-genome-equivalent  in  mouse  tissues. 
RNA:DNA ratios (Fig. 2) were used to determine equal DNA- 
equivalents of RNA (listed below autoradiograms) and this amount 
of RNA was supplemented with yeast RNAto 100 #g. RNase pro- 
tection assays were as above. (B) Polysomal distribution of NF-Yb 
mRNA in liver and testis. Cytoplasmic preparations from liver and 
testis were sedimented in sucrose gradients. An aliquot (25 %) of 
RNA purified from each fraction was supplemented with 50 tzg of 
yeast RNA and hybridized to 5 fm of the NF-Yb riboprobe. The 
control lanes contained probe hybridized to 100/~g yeast RNA. 
RNase protection conditions were as above. Abbreviation: *b, re- 
sidual nondigested NF-Yb probe. 
roughly inversely proportional to the RNA:DNA ratios for 
these tissues (compare Figs. 2 and 5 D), one may predict that 
all six tissues contain an equal number of NF-Ya and Octl 
mRNA molecules per genome-equivalent. This prediction is 
tested for NF-Ya in Fig. 6 A. The amount of total RNA that 
corresponds  to  10  #g  DNA-equivalents  of tissue  was  in- 
cluded in each hybridization. The results confirm that all tis- 
sues contained a similar number of NF-Ya mRNA molecules 
per genome-equivalent. Thus, levels of NF-Ya mRNA (Fig. 
6 A, upper panel) were roughly proportional to levels of NF- 
Ya protein (Fig. 5 B) in all tissues. In contrast, per-genome 
levels of NF-Yb mRNA (Fig. 6 A, lower panel) varied con- 
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NF-Yb protein (Fig.  5  B).  Rather,  NF-Yb  mRNA  was  ex- 
pressed at roughly the same concentration per total RNA in 
all cell types (autoradiogram not shown, but note that the rel- 
ative  signal  intensities  in  Fig.  6  A  are  roughly inversely 
proportional  to  RNA:DNA  ratios).  The  relative cellular 
mRNA and protein or DNA-binding activity levels for Octl, 
NF-Ya, and  NF-Yb  are shown in Fig.  7, A-C.  Each panel 
compares total RNA content to specific mRNA and protein 
levels for each organ type. This graphic presentation demon- 
strates that levels of NF-Ya mRNA, Octl mRNA, NF-Ya pro- 
tein, NF-Yb protein, and Octl DNA-binding activity were in- 
sensitive  to  the  large  differences  in  total  RNA  content 
between the tissues. In contrast, levels of NF-Yb mRNA cor- 
responded fairly well to cellular RNA content (Fig.  7  C). 
Because NF-Yb  mRNA  levels varied directly with  differ- 
ences in RNA:DNA ratios whereas nuclear NF-Yb protein 
levels reflected DNA content, nuclear NF-Yb protein levels 
were likely regulated translationally or posttranslationally. 
One indicator of protein synthesis rates is the number of 
ribosomes engaged on an mRNA (Hershey et al.,  1986). As 
an indication of whether levels of NF-Yb protein escape cell 
size  regulation  translationally  or  posttranslationally,  we 
measured the polysomal distribution of NF-Yb mRNA in a 
large-celled (liver,  RNA:DNA  =  4.7)  and  a  small-celled 
(testis, RNA:DNA  =  1.1) tissue (Fig. 6 B). If NF-Yb were 
translationally regulated, one would predict the mRNA to 
exhibit, on average, one fourth the number of ribosomes per 
message in  liver as  compared to testis  (i.e.,  liver NF-Yb 
mRNA distributed into fractions much nearer the top of the 
gradient than that in testis). In contrast, only a minor frac- 
tion of  the NF-Yb mRNA in both liver and testis was detected 
in fractions 1 and 2 (nonpolysomai fractions). NF-Yb mRNA 
was found in roughly the same distribution in liver and testis 
gradients, which suggests that the translational efficiency of 
NF-Yb was similar in both tissues. Our data suggest that liver 
synthesizes more NF-Yb protein per genome-equivalent than 
testis; however, nuclei from both tissues accumulate a simi- 
lar  steady-state number  of NF-Yb  protein  molecules per 
genome-equivalent (Fig. 5 B). Thus, NF-Yb appears to es- 
cape cell size regulation via a posttranslational mechanism 
(see Discussion). 
Microscopic examination and  measurements  by Wilson 
and Leduc (1948) indicated that liver cells undergo a large 
increase in average size with age.  Consistent with this, we 
find that RNA:DNA ratios in mouse liver increase several- 
fold during liver maturation (Fig. 8). Although the liver from 
newborn rodents exhibits both hepatic and hematopoietic 
functions, livers from both young and old animals are pri- 
marily composed of parenchymal hepatocytes (for review 
see Gumucio and Chianale,  1988). Consistent with this, we 
find that a 2-d-old mouse liver contains 780/~g DNA, which 
is  equivalent  to  2.3  x  108  diploid  genome-equivalents, 
whereas published values indicate the same liver will contain 
1@-106 hematopoietic cells  (Kincade and  Moore,  1977), 
representing less than 1% of the total cell population. Thus, 
maturing  liver provided a  system  wherein  we  could test 
predictions for cell size-dependent regulation of genes en- 
Figure  7.  Quantitative tissue- 
specific differences in relative 
cellular  levels of total  RNA 
and of mRNAs and proteins 
for  ubiquitous  and  tissue- 
enriched  transcription  fac- 
tors. Signal intensifies on au- 
toradiograms were measured 
by  laser  densitometry  and 
quantitatively related to mac- 
romolecule  abundance  by 
comparison  to dilution curves. 
All values were normalized to 
DNA-equivalents; values for 
spleen (smallest average cell 
size) were arbitrarily set at 1.0 
and other values are presented 
as relative to those for spleen. 
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Figure 8. Changes in liver RNA:DNA ratio and in NF-Ya mRNA 
concentration during liver maturation. (Upper  panel) Changes in 
liver RNA:DNA ratios. Total nucleic acid was prepared from the 
livers of mice of various ages (2,  4,  6,  12,  27, and 75 d) and 
RNA:DNA ratios were determined. (Lower  panel) Expression of 
NF-Ya mRNA. RNA was prepared from an aliquot of each total nu- 
cleic acid sample above by sedimentation through cesium cushions. 
For NF-Ya RNase protections, 20 t~g of RNA was used per reaction 
as described above. As a control, a parallel set of  hybridizations was 
performed using 20 #g of RNA from each sample and a probe that 
spanned  a  200-base  EcoRI-Accl  fragment  of the  rat  GAPDH 
cDNA (10 fmol/reaction,  specific activity 55 Ci/ttmol). 
coding ubiquitous proteins in a single organ type under con- 
ditions in which cell sizes, but not cell types, are substan- 
tially different. Concomitant with the increase in RNA:DNA 
ratios, levels of NF-Ya mRNA per total RNA decreased cor- 
respondingly.  In  contrast  to  NF-Ya mRNA,  levels of the 
mRNA encoding glyceraldehyde phosphate dehydrogenase 
(GAPDH),  a  ubiquitous  glycolytic enzyme (Lebherz and 
Rutter, 1967), represented the same proportion of total RNA 
in all samples (Fig. 8). In sum, the results presented above 
support the prediction that, for ubiquitous nuclear proteins 
to be expressed at the same level in all cells, the genes encod- 
ing these proteins must exhibit a mechanism to escape cell 
size regulation. 
Characterization  of a Transcription  Factor That Is Sub- 
ject to Cell Size Regulation.  DBP,  a  liver-enriched tran- 
scription factor, was identified and its cDNA cloned by the 
ability of this protein to bind the "D-site" of the albumin pro- 
moter (Mueller et al.,  1990). Expression of the dbp gene is 
maximal in adult animals during the evening hours. Western 
blots  show  that  DBP  protein  is  enriched  in  liver  nuclei 
(MueUer et al.,  1990; Wuarin and Schibler,  1990; see be- 
low); however, DBP protein can also be detected in lung, 
kidney, spleen, and brain nuclei, albeit at levels severalfold 
below that in liver (Fig. 9 A). All detectable DBP protein is 
nuclear (Wuarin and Schibler, 1990). Despite differences in 
nuclear DBP protein concentrations between tissues, DBP 
mRNA is similarly abundant in RNA harvested from liver, 
lung,  kidney,  spleen,  and  brain  (Fig.  9  A;  Mueller et 
al.,  1990).  Based  on  this  observation,  it  was  originally 
postulated that DBP protein accumulation may be posttran- 
scriptionally controlled (Mueller et al.,  1990). 
Experiments were initiated to identify the causes for DBP 
enrichment in liver nuclei. The polysomal distributions of 
DBP mRNA  in liver and lung were analyzed to compare 
translational efficiencies. Polysome gradients from both tis- 
sues exhibited a similar distribution of DBP mRNA, indicat- 
ing that a similar number of  ribosomes were engaged on each 
DBP  mRNA  molecule  in  both  tissues  (Fig.  9  B);  DBP 
mRNA was not sequestered in the slowly sedimenting RNP 
fractions in lung (fractions 1 and 2). Our data suggest that 
DBP mRNA is translated with similar efficiencies in lung 
and liver. 
Numerous cultured cell lines of hepatic and non-hepatic 
origin were analyzed in  search of an in vitro system that 
would mimic the preferential accumulation of DBP in liver. 
Equal  amounts  of RNA  from several  rodent-derived cell 
lines and from rat liver were compared for endogenous levels 
of DBP mRNA.  Surprisingly, all of the cell lines, whether 
of hepatic or fibroblastic origin, expressed relatively high 
levels of DBP nRNA/total RNA (10-20%  of the maximal 
liver levels). Polysome analysis confirmed that DBP mRNA 
is engaged by ribosomes in "differentiated" hepatoma cells 
(H4.2 &  C2Rev7), "dedifferentiated" hepatoma ceils (H5), 
and fibroblastic L-cells; however none accumulated measur- 
able levels of nuclear DBP protein (data not shown; hepa- 
toma lines characterized in Deschatrette and Weiss,  1974; 
Deschatrette et al., 1980). Thus in terms of DBP accumula- 
tion, all of the cultured cells,  including those that express 
liver-specific markers such as albumin mRNA, exhibited a 
non-liver phenotype. However, further examination revealed 
an important difference that could account for the liver en- 
richment of DBP protein: the cultured hepatoma cells, like 
the cells of lung, spleen, brain, and kidney, are much smaller 
than parenchymal liver cells. 
How could cell size be responsible for the tissue-specific 
distribution of DBP? Because DBP mRNA levels are roughly 
proportional to rRNA levels, protein translated from a given 
number of DBP mRNA molecules should be concentrated 
into far fewer nuclei in large-celled tissues than that synthe- 
sized in small-celled tissues. The data are consistent with the 
model: translational efficiencies for DBP mRNA appeared 
to be similar in liver and lung (Fig. 9 B). Moreover, quan- 
titative comparison of Western blot  signals  based  on the 
standard curve containing dilutions of the liver nuclei indi- 
cates that liver nuclei contained more DBP protein mole- 
cules per genome-equivalent than lung, kidney, spleen, and 
brain nuclei by magnitudes which were proportional to the 
differences in RNA:DNA ratios between these organs (Fig. 
9 A). Indeed, when Western blot and RNase protection as- 
says are both normalized to equal genome-equivalents, our 
data  show  a  very close correlation between total cellular 
RNA content, cellular DBP mRNA levels, and nuclear DBP 
protein levels (Fig. 7 D). This strongly suggests that tissue- 
Schmidt and Schibler Cell Size Regulation  477 Figure 9.  Expression of DBP 
in adult rat tissues.  (A) DBP 
mRNA  and  protein  levels. 
RNA was harvested from the 
indicated  tissues  from a  rat 
killed at 5:30 pm (peak of cir- 
cadian  DBP  mRNA  expres- 
sion, confirmed for all tissues 
studied,  not  shown);  nuclei 
were  prepared  from  tissues 
harvested at 8:30 pm (peak of 
circadian DBP protein expres- 
sion,  Lavery  and  Schibler, 
1993). The upper panel shows 
an  RNase  protection  assay 
using DBP probe and the indi- 
cated  amounts  of total RNA 
per  sample  supplemented 
with yeast RNA to 100/zg. All 
hybridizations  contained  10 
fmol of DBP probe (specific 
activity  55  Ci//zmol).  The 
lower  panel  shows a  West- 
ern  blot  using  the  indicated 
amounts  of sonicated  whole 
nuclei and a rabbit polyclonal 
antibody to DBP OVuarin and 
Schihler,  1990) visualized by 
the ECL method. Dilutions of 
the liver samples allows quantitative comparison of signal intensities between tissue types for both DBP mRNA and protein. (B) Polysomal 
distribution of DBP mRNA. One gram of  liver or lung harvested from a rat at 6:00 pm was homogenized in 10 ml each of a freshly thawed 
50% rat liver cytoplasmic lysate prepared from an animal killed at 8:00 am (a control gradient confirmed that the morning extract did 
not contain significant levels of DBP mRNA; please see Materials and Methods for rationale) and polysome gradients were prepared with 
a  500-/zl aliquot of each lysate. The upper panel shows the absorbance scan of a representative gradient;  fraction  1 is the top of the tube. 
The lower panels shows albumin mRNA- and DBP mRNA-specific RNase protection signals from an aliquot (20% for DBP assays, 2% 
for albumin assays) of  the RNA purified from each fraction of the indicated gradients supplemented with 50 #g (DBP) or 100 #g (albumin) 
yeast RNA. DBP hybridizations were as above; albumin samples were hybridized to 20 fmol probe (specific activity 5.4 Ci/#mol). Because 
lung is somewhat more difficult to homogenize than liver in nondenaturing buffers, quantitative comparisons  of absolute mRNA levels 
between liver and lung cannot be made from the polysome data, but should be referred to A. Abbreviation: D* residual nondigested DBP 
probe. 
specific  nuclear  DBP  protein  levels  were  determined  by 
regulation  of DBP  mRNA  levels.  DBP  mRNA  levels,  in 
turn, matched total RNA levels, suggesting that the dbp gene 
might be subject to cell size regulation. If  this were the case, 
one would  expect tissue-specific DBP mRNA levels,  like 
tissue-specific total RNA levels, to be determined at a tran- 
scriptional level.  Therefore, we tested this prediction. 
Nuclear Control of raRNA Levels for NF-Ya, Oct1, and 
DBP. The levels of NF-Ya, Octl, and DBP proteins generally 
corresponded to levels of their cognate mRNAs in the sam- 
pies  that  we  examined  (see  above).  Therefore,  the  cell 
size-dependent regulation of the cognate genes must occur 
by regulation of either transcription rate or transcript stabil- 
ity.  Transcription  rates  for the  nf-ya and  oct1 genes have 
proven too low to be measured by nuclear run-on assays. For 
this reason,  an assay for nuclear concentrations of NF-Ya, 
Octl, and DBP mRNAs was used to further study the levels 
of regulation.  The rationale behind this assay follows. 
The differences between nuclear and whole cell concentra- 
tions  of albumin mRNA  (concentration  taken as  albumin 
mRNA per total RNA in the sample) in Fig.  10 was roughly 
0.05  (the nuclear RNA lane contained 20-fold more input 
RNA than the whole cell RNA lane for the albumin mRNA 
assay). This shows that cytoplasmic contamination of the nu- 
clear preparations was less than 5 %. For Oct1,  NF-Ya, and 
DBP mRNAs,  the  ratios of nuclear:whole cell concentra- 
tions were all roughly three (nuclear and whole cell lanes 
contained equal amounts of input RNA for Oct1, NF-Ya, and 
DBP mRNA assays). Thus the maximal error due to cyto- 
plasmic contamination (+0.05) was negligible. The kinetics 
of the circadian expression pattern of DBP mRNA indicate 
that its halflife is on the order of 1-2 h  (for mathematical 
model, see Wuarin et al.  [1992]).  Because NF-Ya and Oct1 
mRNA showed nuclear/cytoplasmic distributions similar to 
that for DBP mRNA, all three transcripts likely have simi- 
larly short halflives. For unstable mRNAs such as these, a 
relatively large fraction of the lifetime of the mRNA is ex- 
pected to be spent in the nucleus during synthesis and pro- 
cessing (Wuarin and Schibler, 1994). The high nuclear:cyto- 
plasmic ratio measured for these mRNAs is consistent with 
this prediction. 
Having established that the nuclear preparations were not 
significantly contaminated by cytoplasmic RNA, we asked 
whether the relative expression patterns seen for Oct1,  NF- 
Ya, and DBP mRNAs in whole tissues are determined in the 
nucleus (Fig. 10). Again, in interpreting the data it is impor- 
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nf-ya and oct1 genes likely use a transcriptional mechanism 
to escape cell size regulation. 
Figure 10.  Nuclear  and total 
concentrations of Oct-l,  NF- 
Ya, DBP, and Alb mRNAs in 
liver and spleen. Total RNA 
was prepared from liver and 
spleen of mice and rats killed 
at 5:30 pm (circadian peak of 
DBP mRNA levels).  Nuclei 
were prepared from liver and 
spleen of mice and rats killed 
at  3:00  pm  (circadian  peak 
of DBP transcription, Lavery 
and Schibler, 1993) and nu- 
clear  RNA  was  purified 
through  cesium  cushions. 
RNase protection assays were 
as above except that for albu- 
min, the probe specific activ- 
ivy was 55 Ci/~mol. For Oct-1 
mRNA  determinations,  hy- 
bridizations contained 25 #g 
per lane  of nuclear  or total 
mouse RNA; for NF-Ya, 50 ~g 
of  nuclear  or  total  mouse 
RNA was used; for DBP, 50 
/~g of total rat RNA was used; 
and for albumin mRNA lev- 
els, l0 #g of nuclear or 0.5 #g 
of  total rat RNA were used. In 
all  hybridizations,  samples 
were supplemented with yeast 
RNA to 50/~g. Control lanes 
contained probe plus 65 ~g of 
yeast RNA. Asterisks denote 
residual nondigested probe. 
tant to consider the different RNA:DNA ratios between liver 
and spleen.  Signals in the nuclear lanes represent nuclear 
quantities of transcripts in liver and spleen. In contrast, the 
whole cell RNA lanes reflect the concentrations of Octl, NF- 
Ya, or DBP mRNA, and must be corrected for RNA:DNA 
ratio differences between the tissue types (ll-fold) to esti- 
mate per-genome mRNA levels. The results show that liver 
and spleen have a similar number of nuclear Octl and NF-Ya 
mRNA molecules per genome-equivalent, and similar num- 
bers of total Octl and NF-Ya mRNA molecules per genome- 
equivalent  (Figs.  5,  6,  and  10).  Levels  of nuclear  DBP 
mRNA per DNA also corresponded to levels of whole cell 
DBP mRNA per DNA in both tissues (Figs. 9 and 10), and 
differed  between  tissues  by  a  magnitude  reflecting  the 
RNA:DNA  ratio differences. The correlation between nu- 
clear and whole cell mRNA levels strongly suggests that cel- 
lular levels of these mRNAs were determined in the nucleus. 
Our results are consistent with regulation of all three genes 
at a  transcriptional level. Therefore, we conclude that the 
Discussion 
Cell Size Regulation 
Different cell types within an organism can vary greatly in 
size. In comparing tissues from adult rodents, we found that 
differences in cell size generally corresponded to differences 
in cellular RNA content. Hence, we entitle the mechanisms 
controlling the cell type-specific accumulation of RNA cell 
size regulation. We present data showing a tight correlation 
between transcription rates and RNA:DNA ratios in liver, 
lung, kidney, spleen, brain, and thymus. Therefore, in these 
tissues, the cellular RNA levels, and thus the RNA:DNA ra- 
tios, are likely to be primarily determined by transcriptional 
mechanisms. 
Importantly,  differences in  total transcriptional  activity 
between liver and thymus or spleen (6-26-fold, Fig. 3) were 
similar to differences in pol II-specific transcriptional activ- 
ity between these tissues (10-11-fold,  Table II). As pol II ac- 
tivity represents only ~30%  of the total RNA polymerase 
activity (Roeder, 1974), regulation of pol II alone could not 
account  for  the  difference in  overall  transcription  rates. 
Rather, the activities of pol I and pol III, in combination, 
must also be cell size dependent. For pol II, our data suggest 
that enzyme activities per unit pol II protein differ between 
cell types (Fig. 4). For pol I and pol III, it remains untested 
whether protein levels are regulated. It might be interesting 
in this regard that the genes encoding the subunits of all three 
polymerases are likely to be transcribed by pol II. Thus, it 
is feasible that regulation of pol II activity could regulate lev- 
els of the other polymerases. At this point we remain far 
from understanding the precise molecular mechanisms that 
determine the cell size-dependent transcription rates. 
Little is known about the genetic processes that might de- 
termine how much cytoplasmic material a cell will accumu- 
late, and,  indeed,  we are aware of no cell size mutants in 
mammals. Nevertheless, in an insightful study, Dobzhansky 
(1929) compared cell sizes between wild-type and miniature 
Drosophila mutants. This work showed that individual genes 
can affect, and therefore potentially regulate,  cell size.  A 
more  recent molecular  analysis  of one  miniature  mutant 
mapped the defect to a gene encoding a ribosomal protein 
(Kongsuwan et al., 1985). The observation that the miniature 
phenotype can be caused by a mutation in a ribosomal pro- 
tein suggests that differences in the translational efficiency in 
different cells can lead to different cell sizes. In contrast, we 
found no significant difference in translational efficiency  per 
unit  RNA  between liver and  spleen cells despite  a  large 
difference in  cytoplasmic:nuclear volume ratios  (Fig.  3). 
However, theoretically, both differences in the ability of ribo- 
somes to translate mRNA and differences in the amount of 
mRNA  and  ribosomes which are available for translation 
should have the same ultimate effect: to change the rate of 
cellular protein synthesis. Thus, the miniature mutants indi- 
cate that cell size could be regulated by altering rates of pro- 
tein synthesis, whereas our study extends this possibility by 
suggesting that overall rates of protein synthesis, and thus 
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several rodent tissues. 
Having cell  size differences in metazoan organisms may 
impose constraints on gene regulation that will not necessar- 
ily exist in single-celled organisms.  In multicellular organ- 
isms,  wherein  the  steady-state  cytoplasmic content  of in- 
dividual postreplicative somatic cells can vary by more than 
an order of magnitude, at least two classes of house-keeping 
genes can be distinguished.  The first class encodes compo- 
nents whose numbers are proportional to cell size,  such as 
ribosomes,  tRNAs,  structural  cytoplasmic  proteins,  and 
translation factors. The second class encodes products whose 
numbers match cellular DNA content, such as histones and 
ubiquitous  transcription  factors.  As  discussed  below,  the 
consequences of cell size regulation are particularly intrigu- 
ing for the accumulation of nuclear proteins,  such as tran- 
scription  factors. 
Cell Size and Gene Regulation 
Although  cell  size,  like all  heritable  characteristics,  is  no 
doubt genetically  regulated  (Dobzhansky,  1929),  the  con- 
verse possibility, that specific gene expression patterns might 
be regulated by cell size, has been explored in few situations. 
Classical  work on fission yeast showed that cell size feeds 
back  on cell  cycle progression  through a  mechanism  that 
regulates the expression of specific genes in response to vol- 
ume  (Fantes,  1977;  Fantes  and  Nurse,  1977).  Subsequent 
studies  on  metazoans  suggested  that  similar  mechanisms 
likely contribute universally to patterns  of replication-spe- 
cific gene expression  (Baserga,  1984; Edgar et al.,  1986). 
Also, asymmetric cell divisions which lead to daughter cells 
of different sizes have been correlated to genetic cell fate de- 
termination (for review see Horvitz and Herskowitz,  1992; 
and see Kirk et al.,  1993, for an intriguing analysis).  How- 
ever, to our knowledge, no one has investigated whether the 
vast differences in cell size between postreplicative somatic 
cell types might influence tissue-specific gene expression in 
metazoans. 
We demonstrate that cell size regulation may cause DBP 
protein to accumulate to higher levels in the nuclei of large 
cells, such as parenchymal hepatocytes. Conversely, several 
ubiquitous  transcription  factors apparently require  mecha- 
nisms to ensure cell size-independent accumulation. Fig. 11 
shows a schematic representation of the cell size-dependent 
expression patterns for the three classes of nuclear proteins 
that we studied. In the model, NF-Ya and Octl use transcrip- 
tional mechanisms to match protein levels to DNA content. 
Figure 11. Cell size-dependent regulation  of nuclear 
protein accumulation.  Parameters  that determine the 
nuclear concentrations of NF-Ya, Octl, NF-Yb, and 
DBP are portrayed in hypothetical cells exhibiting six- 
fold differences in RNA:DNA ratios. In the diagrams, 
an equal  tissue-mass  of each cell  type (i.e.,  equal 
RNA-equlvalents)  is shown to emphasize the differ- 
ence in RNA:DNA ratios and the distinction  between 
components expressed at equal numbers or equal con- 
centrations  in the cells or compartments.  Nuclei are 
shown as shaded circles; nuclear proteins are shown 
as dark squares (NF-Ya  or Octl), triangles  (NF-Yb),  or 
ellipses (DBP) in the nuclei,  mRNA levels are shown 
as cytoplasmic monosomes with a nascent  polypep- 
tide to imply mRNA-dependent synthesis  rates.  Al- 
though only one monosome is shown for NF-Ya in the 
large  cell,  the total number of ribosomes (and total 
RNA) will be the same in all of  the large cells (propor- 
tional  to RNA:DNA ratios).  In calculating  protein 
levels,  only the mature nuclear species,  not the na- 
scent polypeptides,  are considered.  The values below 
each diagram correspond to relative  amounts of the 
specific mRNAs or proteins as normalized  to either 
cellular DNA content,  total RNA content, or levels 
of the specific mRNA, as indicated.  The upper panel, 
for NF-Ya and Octl, shows that these genes are regu- 
lated such that both cell types contain an equal num- 
ber of mRNAs for these proteins,  and thus an equal 
number of the cognate proteins  per nucleus.  In the 
middle panel, NF-Yb mRNA levels are expressed  at 
equal concentrations in all cells. Thus, the large cell 
has sixfold more NF-Yb mRNA molecules than any one of the small cells. Protein levels are posttranslationaily  matched to DNA content. 
In the lower panel, DBP mRNA is also expressed  at the same concentration in both cell types.  However, as DBP protein is not matched 
to DNA content, the large cell accumulates more nuclear DBP protein. For simplicity,  the model shows no posttranslational  control of 
NF-Ya, Octl, or DBP levels. Although this is consistent  with our data, we do not wish to imply that other levels of regulation  do not exist 
under conditions that we did not test. It is noteworthy that the ubiquitous proteins  are the same concentration in all nuclei (protein/DNA), 
but different concentrations in the tissues (protein/tissue  mass).  DBP protein is the same concentration in both tissues, but different concen- 
trations between nuclei types. The concentrations of NF-Ya  and Octl mRNAs differ between tissues;  the concentrations of NF-Yb and DBP 
mRNAs arc the same in both tissues. 
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NF-Yb protein are cell size-dependent; protein levels  are 
matched to nuclear content by a posttranslational mecha- 
nism. Finally, transcription of the dbp gene and synthesis of 
DBP protein are also cell size-dependent; however unlike 
NF-Yb, DBP protein is not matched to DNA content. There- 
fore, DBP preferentially accumulates in the nuclei of ceils 
with large RNA:DNA ratios. 
Liver nuclei are larger than thymus or spleen nuclei (Figs. 
1 and 3). Thus, one may ask to what extent differences in 
nuclear volumes could influence the interpretation of our 
data. Since our conclusions are based on data normalized to 
DNA content, the interpretations are not affected by differ- 
ences in ploidy. Also, nuclear transcription factors are prob- 
ably not free in solution. Indeed, when liver nuclei are dis- 
rupted by sonication in large volumes of physiological saline 
with nonionic detergent and chromatin fragments are sedi- 
mented by low-speed centrifugation, DBP protein quantita- 
tively sediments with the chromatin (not shown).  Excess 
recombinant DBP,  if added to nuclei, associates quantita- 
tively with the chromatin (not shown), suggesting that stable 
binding sites for DBP in chromatin are not saturated. This 
renders unlikely the possibility that, while in cells, nuclei 
contain additional DBP which is free in solution and is lost 
during isolation of nuclei. Thus for transcription factors, we 
suspect that the chemical concentrations of the factors in nu- 
clear solute is probably a less important parameter than the 
absolute amount of factor per DNA. 
Escape from Cell Size Regulation.  The term "escape from 
cell size regulation" implies that the expression of most genes 
would be affected by cell size regulation unless they have 
specific signals to override the effect. Indeed, we show that 
overall RNA synthesis rates and total mRNA levels are cell 
size dependent, which suggests that cell size regulation is a 
fairly consummate process.  Moreover,  the nf-yb gene ex- 
hibited cell size-dependent mRNA levels and subsequent 
posttranslational regulation to achieve cell size-independent 
protein levels.  Thus, we have the impression that genes en- 
coding ubiquitous cytoplasmic molecules are subject to the 
"default" regulatory pathway and those encoding ubiquitous 
nuclear products actively escape this control. 
Levels of NF-Ya and Octl mRNAs appear to escape cell 
size regulation by a nuclear mechanism (Fig. 10). The obser- 
vation that amounts of NF-Ya and Octl transcripts in nuclei 
roughly matched amounts of NF-Y and Octl DNA-binding 
activity could readily be explained by a direct feedback inhi- 
bition loop.  In the simplest form of this model, when the 
level of a ubiquitous transcription factor reached a certain 
threshold level, it would downregulate its own gene and pos- 
sibly genes encoding other ubiquitous nuclear products as 
well. This would match transcription rates on these genes to 
DNA content and make expression independent of cell size 
regulation. 
Our data suggest that liver cells, on average, synthesized 
NF-Yb protein at several times the per-genome rate of testis 
cells; yet nuclei from both tissue types exhibited the same 
amount of NF-Yb protein per DNA. This indicates that nu- 
clear levels of this protein were likely determined posttrans- 
lationally. Such an expression pattern could arise by regulat- 
ing NF-Yb nuclear localization, NF-Yb protein stability, or 
both. The sequence of NF-Yb reveals no obvious nuclear lo- 
calization signal (Boulikas,  1993);  however,  we have been 
unable to detect NF-Yb protein accumulation in liver cyto- 
plasm by immunoprecipitation and Western blot analyses 
(not shown). Thus, it appears likely that excess NF-Yb pro- 
tein is degraded in large cells. Because NF-Y is an obligatory 
heteromer containing NF-Ya and NF-Yb  (Chodosh et al., 
1988a,b;  Forsburg and Guarente,  1989;  Hatamochi et al., 
1988; Hooft van Huijsduijnen et al., 1990; Maity et al., 1992; 
Mantovani et al., 1992) and because NF-Ya protein exhibits 
an independent mechanism of escaping cell size regulation 
(see  above),  it is  possible  that NF-Yb  protein  levels are 
matched to NF-Ya protein levels  by a  mechanism that de- 
grades NF-Yb monomer preferentially, analogous to the sys- 
tem which makes stability of IrB dependent on levels  of 
NFrB (Brown et al.,  1993;  Scott et al.,  1993;  Sun et al., 
1993). 
Cell Size May Contribute to 1Issue-Specific Transcrip- 
tion Patterns. A fundamental question in metazoan cell bi- 
ology asks how clonally derived genetically identical cells 
can  establish  and maintain different phenotypes.  Tissue- 
specific transcription has been shown to play important roles 
in cell type specification, but what makes certain transcrip- 
tion factors tissue enriched? In some cases, direct regulation 
by  another  tissue-enriched  transcription  factor  has been 
demonstrated. For example HNF-1 (Courtois et al., 1988), 
a transcription factor that appears to play a role in the liver- 
specific expression of the albumin gene (Cereghini et al., 
1987; Lichtsteiner and Schibler,  1989),  is itself highly en- 
riched in liver nuclei as a result of a transcriptional control 
mechanism in which HNF-4 protein, another liver-enriched 
transcription factor, appears to play a predominant role (Kuo 
et al., 1992; Tian and Schibler, 1991). In other cases, tissue- 
specific transcription factors have been shown to autoacti- 
vate transcription of their own gene via an autoregulatory 
loop, and thus maintain their own tissue specificity (e.g., 
Thayer et al.,  1989; Way and Chalfie, 1989). 
The cell size-dependent expression pattern for DBP pro- 
tein that we outline in this paper provides an interesting al- 
ternative mechanism by which a  transcription factor can 
become tissue enriched. Our data on DBP accumulation re- 
quire neither an upstream liver-specific transcription factor 
nor an autoregulatory loop to explain the liver-enriched ex- 
pression pattern. Rather, the expression pattern for the dbp 
gene appears to be dependent on signals that regulate cellular 
RNA:DNA ratios and, as a consequence, cell size. We sug- 
gest that nuclei of large cells such as parenchymal hepato- 
cytes transcribe the dbp gene, like the genes encoding ubiq- 
uitous cytoplasmic molecules, at a higher rate than the nuclei 
of smaller cells. As DBP protein is exclusively localized to 
the nucleus, it becomes enriched in the nuclei of large cells 
as compared to the nuclei of small cells. 
Cell Size Must Be Considered for Molecular Compari- 
sons between Cell I~pes. To appreciate the practical impor- 
tance of cell size regulation for interpreting data on gene ex- 
pression, one must critically evaluate the denominator for 
each measurement. The purpose of measuring specific tran- 
scription rates or mRNA levels  is to gain insights into the 
mechanisms regulating expression of the cognate genes. It is 
striking in this regard that these measurements are almost 
never normalized to equal gene-equivalents. Northern blot 
analyses and nuclease protection assays are invariably nor- 
malized to bulk RNA (or poly-A+ RNA). Therefore, such 
assays can give no indication of the relative activities of a 
Schmidt  and Schibler Cell Size Regulation  481 specific gene between cell or tissue types unless the total 
RNA contents per genome-equivalent are known and consid- 
ered for all samples. As seen above, DBP mRNA represents 
the same fraction of total RNA in samples from liver and 
spleen, yet because the cell sizes differ, liver accumulates ll- 
fold more DBP mRNA and protein molecules per gene copy 
than spleen.  Conversely,  the fraction of total RNA  repre- 
sented by NF-Ya or Octl mRNAs are 11-fold higher in spleen 
RNA as compared to liver RNA, yet, as a result of cell size 
differences,  these  mRNAs  and  their  cognate proteins  ac- 
cumulate to a very similar number in the two cell types. Cell 
size also has to be considered for in situ hybridization  analy- 
ses, in particular for mRNAs encoding nuclear proteins. As 
suggested  by the diagram  in Fig.  11,  in situ  hybridization 
with probes for DBP mRNA would show uniform signals in 
large and small cells. Conversely,  in situ hybridization  for 
NF-Ya or Octl mRNAs would reveal  much stronger  signals 
in small than in large cells. Unless one is conscious of cell 
size differences, such observations might invite the entirely 
false conclusion that DBP mRNA (and perhaps protein)  is 
equally abundant in all cells and NF-Ya mRNA (and perhaps 
protein) levels are cell type-specific. 
Finally,  overall transcription  rates are cell size dependent 
(Table II, Fig. 3). In nuclear run-on transcription,  overall in- 
corporation is greater  in cells with greater  RNA:DNA  ra- 
tios. As a result, nuclear run-on assays normalized either to 
input radioactivity  in the hybridization  or to specific signals 
obtained with genes encoding ubiquitous cytoplasmic mole- 
cules, such as the commonly used GAPDH or tRNA genes, 
do not compare an equal number of gene copies, and there- 
fore do not reflect relative per-gene RNA polymerase densi- 
ties between nuclei of different cell types. To measure per- 
gene transcription  rates,  the hybridization  signals per input 
radioactivity  must be corrected for differences in the ratio of 
total incorporated radioactivity  per DNA-equivalent. 
We suspect that a simple reevaluation  of existing data on 
cell type-specific gene expression patterns,  after normaliz- 
ing all values to equal genome-equivalents  as the common 
denominator,  may  provide  unexpected  new  insights  into 
gene regulation. 
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